These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 21142815

  • 1. The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction.
    Alp E, Menevse S, Tulmac M, Yilmaz A, Yalcin R, Cengel A.
    Genet Test Mol Biomarkers; 2011 Apr; 15(4):193-202. PubMed ID: 21142815
    [Abstract] [Full Text] [Related]

  • 2. Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study.
    Alp E, Yilmaz A, Tulmac M, Ugras Dikmen A, Cengel A, Yalcin R, Menevse ES.
    Kaohsiung J Med Sci; 2017 Feb; 33(2):78-85. PubMed ID: 28137415
    [Abstract] [Full Text] [Related]

  • 3. Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population.
    Alp E, Menevse S, Tulmac M, Kan D, Yalcin R, Erkan AF, Cengel A.
    DNA Cell Biol; 2009 Jul; 28(7):343-50. PubMed ID: 19435423
    [Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease.
    Jguirim-Souissi I, Jelassi A, Slimani A, Addad F, Hassine M, Hamda KB, Najah M, Maatouk F, Rouis M, Slimane MN.
    Coron Artery Dis; 2011 Jul; 22(6):388-93. PubMed ID: 21606841
    [Abstract] [Full Text] [Related]

  • 5. An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.
    Ashokkumar M, Anbarasan C, Saibabu R, Kuram S, Raman SC, Cherian KM.
    Thromb Res; 2011 Oct; 128(4):e49-53. PubMed ID: 21762961
    [Abstract] [Full Text] [Related]

  • 6. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
    Horne BD, Camp NJ, Carlquist JF, Muhlestein JB, Kolek MJ, Nicholas ZP, Anderson JL.
    Am Heart J; 2007 Oct; 154(4):751-8. PubMed ID: 17893005
    [Abstract] [Full Text] [Related]

  • 7. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
    Román-García P, Coto E, Reguero JR, Cannata-Andía JB, Lozano I, Avanzas P, Morís C, Rodríguez I.
    Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856
    [Abstract] [Full Text] [Related]

  • 8. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
    Diao LP, Ma H, Wei GC, Li T, Liu HS, Liu LH, Wu LL, Zhao GM, Gao YH.
    Int J Cancer; 2012 Sep 01; 131(5):1095-103. PubMed ID: 22020421
    [Abstract] [Full Text] [Related]

  • 9. The relationship between endothelial nitric oxide synthase gene polymorphism (T-786 C) and coronary artery disease in the Turkish population.
    Tangurek B, Ozer N, Sayar N, Terzi S, Yilmaz H, Dayi SU, Ciloglu F, Aksu H, Asilturk R, Cagil A.
    Heart Vessels; 2006 Sep 01; 21(5):285-90. PubMed ID: 17151815
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A, Goldbergová M, Izakovicová Hollá L, Sisková L, Groch L, Beránek M, Tschöplová S, Znojil V, Vácha J.
    Matrix Biol; 2004 Jan 01; 22(7):585-91. PubMed ID: 14996438
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association of the genetic variants of endothelial nitric oxide synthase gene with angiographically defined coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus.
    Narne P, Ponnaluri KC, Singh S, Siraj M, Ishaq M.
    J Diabetes Complications; 2013 Jan 01; 27(3):255-61. PubMed ID: 23182401
    [Abstract] [Full Text] [Related]

  • 14. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
    Ozkök E, Aydin M, Babalik E, Ozbek Z, Ince N, Kara I.
    Med Sci Monit; 2008 Oct 01; 14(10):CR536-42. PubMed ID: 18830194
    [Abstract] [Full Text] [Related]

  • 15. Association of the gene polymorphisms of platelet glycoprotein Ia and IIb/IIIa with myocardial infarction and extent of coronary artery disease in the Korean population.
    Park S, Park HY, Park C, Ko YG, Im EK, Jo I, Shin C, Lee JB, Shim WH, Cho SY, Jang Y.
    Yonsei Med J; 2004 Jun 30; 45(3):428-34. PubMed ID: 15227729
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.
    Haberbosch W, Unkelbach K, Schuster D, Gardemann A, Tillmanns H, Hölschermann H.
    Thorac Cardiovasc Surg; 2009 Oct 30; 57(7):386-90. PubMed ID: 19795323
    [Abstract] [Full Text] [Related]

  • 19. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
    Gouda HM, Khorshied MM, El Sissy MH, Shaheen IA, Mohsen MM.
    Ann Hematol; 2014 Aug 30; 93(8):1313-8. PubMed ID: 24627195
    [Abstract] [Full Text] [Related]

  • 20. Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.
    Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I.
    Clin Chim Acta; 2012 Jan 18; 413(1-2):113-20. PubMed ID: 21963461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.